Allosteric inhibition of the proteasome.

被引：0
|
作者：
Kisselev, AF [1 ]
机构：
[1] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 222卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
156-MEDI
引用
收藏
页码：U665 / U665
页数：1
相关论文
共 50 条
  • [41] Proteasome inhibition as an anticancer target
    Irena Melnikova
    James Golden
    Nature Reviews Drug Discovery, 2005, 4 (8) : 698 - 698
  • [42] Proteasome Inhibition in Cancer Therapy
    Smith, Gina G.
    JOURNAL OF INFUSION NURSING, 2005, 28 (04) : 258 - 264
  • [43] The value of proteasome inhibition in cancer
    Cvek, Boris
    Dvorak, Zdenek
    DRUG DISCOVERY TODAY, 2008, 13 (15-16) : 716 - 722
  • [44] Bivalency as a principle for proteasome inhibition
    Loidl, G
    Groll, M
    Musiol, HJ
    Huber, R
    Moroder, L
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) : 5418 - 5422
  • [45] Allosteric Inhibition of the Neuropeptidase Neurolysin
    Hines, Christina S.
    Ray, Kallol
    Schmidt, Jack J.
    Xiong, Fei
    Feenstra, Rolf W.
    Pras-Raves, Mia
    de Moes, Jan Peter
    Lange, Jos H. M.
    Melikishvili, Manana
    Fried, Michael G.
    Mortenson, Paul
    Charlton, Michael
    Patel, Yogendra
    Courtney, Stephen M.
    Kruse, Chris G.
    Rodgers, David W.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (51) : 35605 - 35619
  • [46] Pharmacogenomics of proteasome inhibition.
    Wang, L.
    Pelleymounter, L.
    Moon, I.
    Kumar, S.
    Weinshilbourn, R.
    Greipp, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S88 - S88
  • [47] Allosteric coupling between α-rings of the 20S proteasome
    Yu, Zanlin
    Yu, Yadong
    Wang, Feng
    Myasnikov, Alexander G.
    Coffino, Philip
    Cheng, Yifan
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [48] Proteasome inhibition and multiple myeloma
    Kanagasabaphy, Pamela
    Morgan, Gareth J.
    Davies, Faith E.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (06) : 447 - 451
  • [49] The clinical potential of proteasome inhibition
    Anderson, KC
    EJC SUPPLEMENTS, 2004, 2 (06): : 3 - 6
  • [50] Proteasome inhibition as an anticancer target
    Constantine S. Mitsiades
    Paul G. Richardson
    Kenneth C. Anderson
    Nature Reviews Drug Discovery, 2005, 4 (8) : 698 - 698
12345